The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice

Yousuf M. Al Suleimani, Aly M. Abdelrahman, Turan Karaca, Priyadarsini Manoj, Mohammed Ashique, Abderrahim Nemmar, Badreldin H. Ali

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study aimed at investigating the possible ameliorative effects of sitagliptin in mice with gentamicin (GEN) nephrotoxicity. Sitagliptin was given to the animals at an oral dose of 10 mg kg−1 per day for 10 days, and in some of these mice, GEN was injected intraperitoneally at a dose of 100 mg kg−1 per day during the last seven days of the treatment. Nephrotoxicity was evaluated histopathologically by light microscopy and biochemically by measuring several indices in plasma, urine and renal cortex homogenates. GEN treatment induced nephrotoxicity as evidenced by significantly (P < 0.0001) increasing the plasma concentrations of urea, creatinine, circulatory cytokines, cystatin C, sclerostin, and TNFα. Treatment with GEN also significantly elevated urinary N-acetyl-β-D glucosaminidase (NAG) concentration (P < 0.0001). Moreover, GEN caused significant increase in oxidative stress in the kidneys (P < 0.0001). Histopathological examination revealed massive tubular injury, necrosis, infiltration of inflammatory cells and intraluminal hyaline casts in mice treated with GEN. Sitagliptin alone did not significantly affect any of the indices measured. However, concomitant treatment with sitagliptin and GEN significantly mitigated most of the nephrotoxic actions of GEN. Pending further studies, sitagliptin may potentially be useful as a nephroprotectant agent.

Original languageEnglish
Pages (from-to)1102-1108
Number of pages7
JournalBiomedicine and Pharmacotherapy
Volume97
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Dipeptidyl-Peptidase IV Inhibitors
Gentamicins
Kidney
Cystatin C
Hexosaminidases
Hyalin
Sitagliptin Phosphate
Urea
Microscopy
Creatinine
Oxidative Stress
Necrosis
Urine
Cytokines
Light

Keywords

  • Gentamicin
  • Mice
  • Nephroprotection
  • Nephrotoxicity
  • Sitagliptin

ASJC Scopus subject areas

  • Pharmacology

Cite this

The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice. / Al Suleimani, Yousuf M.; Abdelrahman, Aly M.; Karaca, Turan; Manoj, Priyadarsini; Ashique, Mohammed; Nemmar, Abderrahim; Ali, Badreldin H.

In: Biomedicine and Pharmacotherapy, Vol. 97, 01.01.2018, p. 1102-1108.

Research output: Contribution to journalArticle

@article{a5fde912bad949de99b571844c1a0842,
title = "The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice",
abstract = "This study aimed at investigating the possible ameliorative effects of sitagliptin in mice with gentamicin (GEN) nephrotoxicity. Sitagliptin was given to the animals at an oral dose of 10 mg kg−1 per day for 10 days, and in some of these mice, GEN was injected intraperitoneally at a dose of 100 mg kg−1 per day during the last seven days of the treatment. Nephrotoxicity was evaluated histopathologically by light microscopy and biochemically by measuring several indices in plasma, urine and renal cortex homogenates. GEN treatment induced nephrotoxicity as evidenced by significantly (P < 0.0001) increasing the plasma concentrations of urea, creatinine, circulatory cytokines, cystatin C, sclerostin, and TNFα. Treatment with GEN also significantly elevated urinary N-acetyl-β-D glucosaminidase (NAG) concentration (P < 0.0001). Moreover, GEN caused significant increase in oxidative stress in the kidneys (P < 0.0001). Histopathological examination revealed massive tubular injury, necrosis, infiltration of inflammatory cells and intraluminal hyaline casts in mice treated with GEN. Sitagliptin alone did not significantly affect any of the indices measured. However, concomitant treatment with sitagliptin and GEN significantly mitigated most of the nephrotoxic actions of GEN. Pending further studies, sitagliptin may potentially be useful as a nephroprotectant agent.",
keywords = "Gentamicin, Mice, Nephroprotection, Nephrotoxicity, Sitagliptin",
author = "{Al Suleimani}, {Yousuf M.} and Abdelrahman, {Aly M.} and Turan Karaca and Priyadarsini Manoj and Mohammed Ashique and Abderrahim Nemmar and Ali, {Badreldin H.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.biopha.2017.10.107",
language = "English",
volume = "97",
pages = "1102--1108",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice

AU - Al Suleimani, Yousuf M.

AU - Abdelrahman, Aly M.

AU - Karaca, Turan

AU - Manoj, Priyadarsini

AU - Ashique, Mohammed

AU - Nemmar, Abderrahim

AU - Ali, Badreldin H.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This study aimed at investigating the possible ameliorative effects of sitagliptin in mice with gentamicin (GEN) nephrotoxicity. Sitagliptin was given to the animals at an oral dose of 10 mg kg−1 per day for 10 days, and in some of these mice, GEN was injected intraperitoneally at a dose of 100 mg kg−1 per day during the last seven days of the treatment. Nephrotoxicity was evaluated histopathologically by light microscopy and biochemically by measuring several indices in plasma, urine and renal cortex homogenates. GEN treatment induced nephrotoxicity as evidenced by significantly (P < 0.0001) increasing the plasma concentrations of urea, creatinine, circulatory cytokines, cystatin C, sclerostin, and TNFα. Treatment with GEN also significantly elevated urinary N-acetyl-β-D glucosaminidase (NAG) concentration (P < 0.0001). Moreover, GEN caused significant increase in oxidative stress in the kidneys (P < 0.0001). Histopathological examination revealed massive tubular injury, necrosis, infiltration of inflammatory cells and intraluminal hyaline casts in mice treated with GEN. Sitagliptin alone did not significantly affect any of the indices measured. However, concomitant treatment with sitagliptin and GEN significantly mitigated most of the nephrotoxic actions of GEN. Pending further studies, sitagliptin may potentially be useful as a nephroprotectant agent.

AB - This study aimed at investigating the possible ameliorative effects of sitagliptin in mice with gentamicin (GEN) nephrotoxicity. Sitagliptin was given to the animals at an oral dose of 10 mg kg−1 per day for 10 days, and in some of these mice, GEN was injected intraperitoneally at a dose of 100 mg kg−1 per day during the last seven days of the treatment. Nephrotoxicity was evaluated histopathologically by light microscopy and biochemically by measuring several indices in plasma, urine and renal cortex homogenates. GEN treatment induced nephrotoxicity as evidenced by significantly (P < 0.0001) increasing the plasma concentrations of urea, creatinine, circulatory cytokines, cystatin C, sclerostin, and TNFα. Treatment with GEN also significantly elevated urinary N-acetyl-β-D glucosaminidase (NAG) concentration (P < 0.0001). Moreover, GEN caused significant increase in oxidative stress in the kidneys (P < 0.0001). Histopathological examination revealed massive tubular injury, necrosis, infiltration of inflammatory cells and intraluminal hyaline casts in mice treated with GEN. Sitagliptin alone did not significantly affect any of the indices measured. However, concomitant treatment with sitagliptin and GEN significantly mitigated most of the nephrotoxic actions of GEN. Pending further studies, sitagliptin may potentially be useful as a nephroprotectant agent.

KW - Gentamicin

KW - Mice

KW - Nephroprotection

KW - Nephrotoxicity

KW - Sitagliptin

UR - http://www.scopus.com/inward/record.url?scp=85033402021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033402021&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2017.10.107

DO - 10.1016/j.biopha.2017.10.107

M3 - Article

VL - 97

SP - 1102

EP - 1108

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

ER -